Personal information

Other IDs

SciProfiles: 2462106

Biography

HEmatology
MEdical Oncology

Activities

Collapse all

Employment (1)

Instituto Nacional de Cancerologia: Mexico, DF, MX

Employment
Source: Self-asserted source
Myrna Candelaria

Education and qualifications (2)

Universidad Nacional Autonoma de Mexico Instituto de Investigaciones Biomedicas: México, DF, MX

Education
Source: Self-asserted source
Myrna Candelaria

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran: Tlalpan, DF, MX

Education
Source: Self-asserted source
Myrna Candelaria

Works (6)

Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients

International Journal of Molecular Sciences
2024-08-28 | Journal article
DOI: 10.3390/ijms25179328
Contributors: Myrna Candelaria; Dennis Cerrato-Izaguirre; Olga Gutierrez; Jose Diaz-Chavez; Alejandro Aviles; Alfonso Dueñas-Gonzalez; Luis Malpica
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma

Cancers
2022-09-24 | Journal article
DOI: 10.3390/cancers14194650
Contributors: José Díaz-Chávez; Olga Gutiérrez-Hernández; Lucia Taja-Chayeb; Sindy Gutiérrez-Chavarría; Alejandro Avilés-Salas; Myrna Candelaria
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Mutations at Codon 641 of Exon 16 of EZH2 in Circulating Tumor DNA: A Biomarker for Relapse in Patients With Diffuse Large B-cell Lymphoma Treated With the R-CHOP Scheme.

2022-01-07 | Preprint
DOI: 10.21203/rs.3.rs-1190066/v1
Contributors: José Díaz-Chávez; Olga Gutiérrez-Hernández; Lucia Taja-Chayeb; Sindy Gutiérrez-Chavarría; Alejandro Aviles-Salas; Myrna Candelaria
Source: check_circle
Crossref

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma

Therapeutic Advances in Hematology
2021-01 | Journal article
DOI: 10.1177/2040620721989579
Contributors: Myrna Candelaria; Alfonso Dueñas-Gonzalez
Source: check_circle
Crossref

Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study

Leukemia & Lymphoma
2019-12-06 | Journal article
DOI: 10.1080/10428194.2019.1633632
Contributors: Myrna Candelaria; Derlis E. González; Marcia Torresan Delamain; Daniel Oscar Bär; Surender Kumar Beniwal; Lokanatha Dasappa; David Hugo Flores; John Querol; Toh See Guan; Oleg Nikolaevich Lipatov et al.
Source: check_circle
Crossref

Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS)

Annals of Hematology
2017-11 | Journal article
DOI: 10.1007/s00277-017-3103-x
Contributors: Myrna Candelaria; Sebastian Burgos; Mayra Ponce; Ramiro Espinoza; Alfonso Dueñas-Gonzalez
Source: check_circle
Crossref

Peer review (2 reviews for 1 publication/grant)

Review activity for BioDrugs. (2)
How many people are using ORCID?